Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · July 16, 2023

Diagnostic Accuracy of Noninvasive Assessment of Liver Disease Severity in Patients With NAFLD and Type 2 Diabetes

Hepatology (Baltimore, Md.)


Additional Info

Hepatology (Baltimore, Md.)
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
Hepatology 2023 Jul 01;78(1)195-211, G Pennisi, M Enea, V Falco, GP Aithal, N Palaniyappan, Y Yilmaz, J Boursier, C Cassinotto, V de Lédinghen, WK Chan, S Mahadeva, P Eddowes, P Newsome, T Karlas, J Wiegand, VW Wong, JM Schattenberg, C Labenz, W Kim, MS Lee, M Lupsor-Platon, JFL Cobbold, JG Fan, F Shen, K Staufer, M Trauner, R Stauber, A Nakajima, M Yoneda, E Bugianesi, R Younes, S Gaia, MH Zheng, C Cammà, QM Anstee, FE Mózes, M Pavlides, S Petta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading